GLP-1 Drug Use For Weight Loss Has Soared, Costing Billions
TUESDAY, April 1, 2025 (HealthDay News) — The number of Americans taking cutting-edge weight-loss drugs like Ozempic, Wegovy and Zepbound has skyrocketed in recent years, a new study says. The number of people without diabetes taking a GLP-1 drug more than tripled between 2018 and 2022 in the U.S., researchersContinue Reading